Ignite Creation Date:
2024-05-06 @ 3:26 PM
Last Modification Date:
2024-10-26 @ 1:49 PM
Study NCT ID:
NCT04635384
Status:
RECRUITING
Last Update Posted:
2022-07-19
First Post:
2020-10-28
Brief Title:
Assessment of Chimerism and Relapse Post Bone MarrowHematopoietic Cell Transplant HCT Using AlloHeme Test
Sponsor:
Organization:
CareDx
Study Design
Study Type:
OBSERVATIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
False
Target Duration:
None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
SAMPLES_WITH_DNA
Bio Spec Description:
AlloHeme is a chimerism test service that utilizes NGS technology to analyze SNP loci to quantify donor and recipient cells by measuring genomic DNA Before transplant patient and donor peripheral blood sample will be collected to identify informative marker for routine chimerism testing and baseline establishment for AlloHeme Post-transplant blood or bone marrow samples are obtained and compared to the baseline sample profiles to calculate chimerism of recipient cells in the blood andor bone marrow samples
Enrollment Count:
260
Enrollment Type:
ESTIMATED
Design Primary Purpose:
Design Masking:
Phases:
Observational Models:
| Name |
|---|
| Cohort |
Time Perspective List:
Clinical Trial Statuses
| Name |
|---|
| 70100 |
Who Masked List: